AI predicting brain cancer recurrence represents a groundbreaking advancement in pediatric oncology, promising tailored solutions for young patients battling gliomas.A recent Harvard study revealed that an artificial intelligence tool significantly outperformed traditional methods in forecasting relapse risks for children facing these brain tumors.